Internal standard selection for the high-performance liquid chromatography tandem mass spectroscopy assay of everolimus in blood [3]

Therapeutic Drug Monitoring

Volumn 29, Issue 5, 2007, Pages 673-674

  Hoogtanders, Karin ^a   Van Der Heijden, Jaques ^a   Stolk, Leo M L ^a   Neef, Cees ^a   Christiaans, Maarten ^a   Van Hooff, Johannes ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

32 DESMETHOXYRAPAMYCIN; 40 O (3' HYDROXY)PROPYLRAPAMYCIN; ASCOMYCIN; EDETIC ACID; EVEROLIMUS; RAPAMYCIN DERIVATIVE; UNCLASSIFIED DRUG;

BLOOD SAMPLING; DRUG BLOOD LEVEL; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LABORATORY TEST; LETTER; PRIORITY JOURNAL; STANDARD; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MASS SPECTROMETRY; REFERENCE STANDARDS; SIROLIMUS;

EID: 34848887215     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/FTD.0b013e318156ea84     Document Type: Letter

References (2)

1. Taylor PJ. Internal standard selection for immunosuppressant drugs measured by highperformance liquid chromatography tandem mass spectrometry. Ther Drug Monit. 2007;29:131-132.
2. Korecka M, Solari SG, Shaw LM. Sensitive, high throughput HPLC-MS/MS method with on-line sample clean-up for everolimus measurement. Ther Drug Monit. 2006;28:484-490.